| __timestamp | Taro Pharmaceutical Industries Ltd. | Verona Pharma plc |
|---|---|---|
| Wednesday, January 1, 2014 | 91733000 | 1802274 |
| Thursday, January 1, 2015 | 87644000 | 2512761 |
| Friday, January 1, 2016 | 92365000 | 2894488 |
| Sunday, January 1, 2017 | 85656000 | 8096274 |
| Monday, January 1, 2018 | 88196000 | 7985229 |
| Tuesday, January 1, 2019 | 89971000 | 8994597 |
| Wednesday, January 1, 2020 | 93413000 | 29772000 |
| Friday, January 1, 2021 | 91355000 | 33907000 |
| Saturday, January 1, 2022 | 113676000 | 26579000 |
| Sunday, January 1, 2023 | 198366000 | 49868547 |
| Monday, January 1, 2024 | 218935000 |
Unleashing insights
In the ever-evolving pharmaceutical landscape, effective cost management is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Verona Pharma plc and Taro Pharmaceutical Industries Ltd. over the past decade. Taro Pharmaceutical has consistently maintained higher SG&A expenses, peaking in 2024 with a staggering 118% increase from 2014. In contrast, Verona Pharma's expenses have shown a more volatile trajectory, with a notable surge in 2023, marking a 2,667% increase from 2014. This disparity highlights differing strategic approaches: Taro's steady investment in operational efficiency versus Verona's aggressive scaling efforts. The absence of data for Verona in 2024 suggests a potential shift or reevaluation in their financial strategy. As these companies navigate the complexities of the pharmaceutical industry, their SG&A trends offer valuable insights into their operational priorities and market positioning.
Selling, General, and Administrative Costs: Eli Lilly and Company vs Verona Pharma plc
Who Optimizes SG&A Costs Better? AbbVie Inc. or Verona Pharma plc
SG&A Efficiency Analysis: Comparing Novartis AG and Verona Pharma plc
Who Optimizes SG&A Costs Better? Bristol-Myers Squibb Company or Taro Pharmaceutical Industries Ltd.
Who Optimizes SG&A Costs Better? Lantheus Holdings, Inc. or Taro Pharmaceutical Industries Ltd.
Verona Pharma plc and ADMA Biologics, Inc.: SG&A Spending Patterns Compared
Cost Management Insights: SG&A Expenses for Verona Pharma plc and Xenon Pharmaceuticals Inc.
Comparing SG&A Expenses: Verona Pharma plc vs MiMedx Group, Inc. Trends and Insights
Breaking Down SG&A Expenses: Rhythm Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.
ACADIA Pharmaceuticals Inc. vs Taro Pharmaceutical Industries Ltd.: SG&A Expense Trends
Who Optimizes SG&A Costs Better? Supernus Pharmaceuticals, Inc. or Taro Pharmaceutical Industries Ltd.
Who Optimizes SG&A Costs Better? Amphastar Pharmaceuticals, Inc. or Taro Pharmaceutical Industries Ltd.